Treatment of PD-1(-/-) mice with amodiaquine and anti-CTLA4 leads to liver injury similar to idiosyncratic liver injury in patients (Q51109085)

From Wikidata

Jump to navigation Jump to search

scientific article published on 23 February 2015

edit

Language	Label	Description	Also known as
English	Treatment of PD-1(-/-) mice with amodiaquine and anti-CTLA4 leads to liver injury similar to idiosyncratic liver injury in patients	scientific article published on 23 February 2015

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25283142

retrieved

30 March 2018

reference URL

http://europepmc.org/abstract/MED/25283142

title

Treatment of PD-1(-/-) mice with amodiaquine and anti-CTLA4 leads to liver injury similar to idiosyncratic liver injury in patients (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25283142

retrieved

30 March 2018

reference URL

http://europepmc.org/abstract/MED/25283142

main subject

amodiaquine

0 references

author name string

Imir G Metushi

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25283142

retrieved

30 March 2018

reference URL

http://europepmc.org/abstract/MED/25283142

M Anthony Hayes

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25283142

retrieved

30 March 2018

reference URL

http://europepmc.org/abstract/MED/25283142

Jack Uetrecht

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25283142

retrieved

30 March 2018

reference URL

http://europepmc.org/abstract/MED/25283142

language of work or name

English

0 references

publication date

23 February 2015

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25283142

retrieved

30 March 2018

reference URL

http://europepmc.org/abstract/MED/25283142

published in

Hepatology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25283142

retrieved

30 March 2018

reference URL

http://europepmc.org/abstract/MED/25283142

volume

61

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25283142

retrieved

30 March 2018

reference URL

http://europepmc.org/abstract/MED/25283142

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25283142

retrieved

30 March 2018

reference URL

http://europepmc.org/abstract/MED/25283142

page(s)

1332-1342

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25283142

retrieved

30 March 2018

reference URL

http://europepmc.org/abstract/MED/25283142

cites work

Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.27549

retrieved

21 January 2018

Animal models of idiosyncratic drug reactions

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.27549

retrieved

21 January 2018

Idiosyncratic adverse drug reactions: current concepts

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.27549

retrieved

21 January 2018

A Fresh Look at the Mechanism of Isoniazid-Induced Hepatotoxicity

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.27549

retrieved

21 January 2018

HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.27549

retrieved

21 January 2018

A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.27549

retrieved

21 January 2018

Evaluation of drug-induced serious hepatotoxicity (eDISH): application of this data organization approach to phase III clinical trials of rivaroxaban after total hip or knee replacement surgery

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.27549

retrieved

21 January 2018

Idiosyncratic liver injury: challenges and approaches.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.27549

retrieved

21 January 2018

The liver as a site of T-cell apoptosis: graveyard, or killing field?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.27549

retrieved

21 January 2018

Cbl-b and itch: key regulators of peripheral T-cell tolerance

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.27549

retrieved

21 January 2018

The blockade of immune checkpoints in cancer immunotherapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.27549

retrieved

21 January 2018

Development of a novel mouse model of amodiaquine-induced liver injury with a delayed onset

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.27549

retrieved

21 January 2018

Amodiaquine-induced hepatitis. A report of seven cases

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.27549

retrieved

21 January 2018

Direct oxidation and covalent binding of isoniazid to rodent liver and human hepatic microsomes: humans are more like mice than rats

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.27549

retrieved

21 January 2018

Hepatocyte entry leads to degradation of autoreactive CD8 T cells

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.27549

retrieved

21 January 2018

Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.27549

retrieved

21 January 2018

Using genome-wide association studies to identify genes important in serious adverse drug reactions

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.27549

retrieved

21 January 2018

Hy's law: predicting serious hepatotoxicity

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.27549

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.27549

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Amodiaquine induced agranulocytosis and liver damage.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.27549

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1002/HEP.27549

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25283142

retrieved

30 March 2018

reference URL

http://europepmc.org/abstract/MED/25283142

PubMed publication ID

25283142

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25283142

retrieved

30 March 2018

reference URL

http://europepmc.org/abstract/MED/25283142

ResearchGate publication ID

266564090

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51109085&oldid=2268097449"